These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11038905)

  • 41. Total glucosides of Danggui Buxue Tang attenuates bleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodelling.
    Gao J; Feng LJ; Huang Y; Li P; Xu DJ; Li J; Wu Q
    J Pharm Pharmacol; 2012 Jun; 64(6):811-20. PubMed ID: 22571259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pulmonary cellular proliferation and its control during development of pulmonary hypertension].
    Cai YN
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):298-302. PubMed ID: 1302362
    [No Abstract]   [Full Text] [Related]  

  • 43. [The phenotypic change of smooth muscle cells in the media of pulmonary intra-acinar arteries during hypoxia].
    Song W; Cai Y; Deng X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Aug; 16(4):255-8. PubMed ID: 7867091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of pulmonary arterial angiotensin converting enzyme in development of hypoxic pulmonary hypertension].
    Cai C; Zou X; Xin D
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):215-7. PubMed ID: 10072805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Traditional Chinese medicine therapy of secondly hypoxia pulmonary arterial hypertension caused by chronic obstructive pulmonary diseases].
    Jiao L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Nov; 20(11):867-8. PubMed ID: 11938837
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical and experimental studies of feiyaning in treating pulmonary arterial hypertension in cor pulmonale].
    Liu SM; Tang TQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Aug; 14(8):469-73. PubMed ID: 7841754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension.
    Botney MD
    Am J Respir Crit Care Med; 1999 Feb; 159(2):361-4. PubMed ID: 9927344
    [No Abstract]   [Full Text] [Related]  

  • 48. [The relationship of intraacinar pulmonary arterial structural remodelling with pulmonary hypertension].
    Wu Y; Che D; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 1995 Apr; 24(2):86-9. PubMed ID: 7788734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nifedipine in the treatment of pulmonary hypertension. II--Hypoxic pulmonary hypertension].
    Barreto BM; de Freitas FM
    Arq Bras Cardiol; 1986 Jun; 46(6):425-9. PubMed ID: 3579636
    [No Abstract]   [Full Text] [Related]  

  • 50. Bortezomib alleviates experimental pulmonary arterial hypertension.
    Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
    Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of collagen production by medial smooth muscle cells in hypoxic pulmonary hypertension.
    Crouch EC; Parks WC; Rosenbaum JL; Chang D; Whitehouse L; Wu LJ; Stenmark KR; Orton EC; Mecham RP
    Am Rev Respir Dis; 1989 Oct; 140(4):1045-51. PubMed ID: 2478055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.
    Hislop A; Reid L
    Br J Exp Pathol; 1976 Oct; 57(5):542-54. PubMed ID: 136978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered expression of genes profiles modulated by a combination of Astragali Radix and Angelicae Sinensis Radix in obstructed rat kidney.
    Meng L; Van Putten V; Qu L; Nemenoff RA; Shang MY; Cai SQ; Li X
    Planta Med; 2010 Sep; 76(13):1431-8. PubMed ID: 20195958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effects of Mongolia Astragali Radix in protecting early cardiac and nephritic functions of patients of hypertension with metabolic syndrome].
    Li NY; Li XL; Zhai XP; Wang QY; Zhang XW; Zhao F; Wang XF; Fan JY; Bai F; Yu J
    Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4051-4059. PubMed ID: 28929695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A pathological survey of the therapeutic effect on experimental hypoxic-ischemic encephalopathy].
    Zhang L; Cai L; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):102-4. PubMed ID: 9206216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plexogenic arteriopathy.
    Wagenvoort CA
    Thorax; 1994; 49 Suppl(Suppl):S39-45. PubMed ID: 7974326
    [No Abstract]   [Full Text] [Related]  

  • 57. Unexplained plexogenic pulmonary arteriopathy: an unusual rapidly progressive case in childhood.
    Coli A; Ammirati A; Dina MA
    Acta Cardiol; 1988; 43(1):55-60. PubMed ID: 3259775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoxic growth of bovine pulmonary artery smooth muscle cells: dependence on synergy, heterogeneity, and injury-induced phenotypic change.
    Dempsey EC; Das M; Frid MG; Xu Y; Stenmark KR
    Chest; 1998 Jul; 114(1 Suppl):29S-30S. PubMed ID: 9676612
    [No Abstract]   [Full Text] [Related]  

  • 59. Vascular connective tissue is rapidly degraded during early regression of pulmonary hypertension.
    Tozzi CA; Wilson FJ; Yu SY; Bannett RF; Peng BW; Riley DJ
    Chest; 1991 Mar; 99(3 Suppl):41S-42S. PubMed ID: 1847675
    [No Abstract]   [Full Text] [Related]  

  • 60. The committed vascular smooth muscle cell: a question of "timing" or "response to pressure" or both.
    Rabinovitch M
    Am J Respir Cell Mol Biol; 1997 Apr; 16(4):364-5. PubMed ID: 9115745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.